- Rubio Rivas M, Corbella X, Guillén Castillo A, Tolosa Vilella C, Colunga Argüelles D, Argibay A, Vargas Hitos JA, Todolí Parra JA, González Echávarri C, Ortego Centeno N, Trapiella Martínez L, Rodríguez Carballeira M, Marín Ballvé A, Pla Salas X, Perales Fraile I, Chamorro AJ, Madroñero Vuelta AB, Freire M, Ruiz Muñoz M, González García A, Pons Martín Del Campo I, Sánchez García ME, Bernal Bello D, Espinosa G, García Hernández FJ, Sáez Comet L, Ríos Blanco JJ, Fernández de la Puebla Giménez RÁ, Sánchez Trigo S, Fonollosa Pla V, Simeón Aznar CP, RESCLE I, Autoimmune Diseases Study Group (. Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507]. AUTOIMMUN REV. 2021;20(5):102793-102793. doi:10.1016/j.autrev.2021.102793. IF:9,75.
- Rubio Rivas M, Homs NA, Cuartero D, Corbella X. The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis. AUTOIMMUN REV. 2021;20(1):102713-102713. doi:10.1016/j.autrev.2020.102713. IF:9,75.
- Riera Mestre A, Iriarte A, Moreno M, del Castillo R, Lopez Wolf D. Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19. Angiogenesis. 2021;24(1):13-15. doi:10.1007/s10456-020-09755-5. IF:9,60.
- Solanich X, Rigo Bonnin R, Gumucio VD, Bastard P, Rosain J, Philippot Q, Perez Fernandez XL, Fuset Cabanes MP, Gordillo Benitez MÁ, Suarez Cuartin G, Boza Hernandez E, Riera Mestre A, Parra Martínez A, Colobran R, Antolí A, Navarro S, Rocamora Blanch G, Framil M, Calatayud L, Corbella X, Casanova JL, Morandeira F, Sabater Riera J. Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona. J. Clin. Immunol. 2021;41(8):1-12. doi:10.1007/s10875-021-01136-x. IF:8,32.
- Pestana Fernandez M, Rubio Rivas M, Tolosa Vilella C, Guillen Castillo A, Colunga Arguelles D, Argibay A, Mari Alfonso B, Marin Ballve A, Pla Salas X, Chamorro AJ, Castro Salomo A, Madronero Vuelta AB, Sanchez Garcia ME, Saez Comet L, Gonzalez Echavarri C, Ortego Centeno N, Vargas Hitos JA, Todoli Parra JA, Trapiella Martinez L, Lledo GM, Freire M, Fonollosa Pla V, Simeon Aznar CP, RESCLE I, Autoimmune Dis Study GEAS GRP. The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i). Rheumatology (Oxford). 2021;60(2):872-880. doi:10.1093/rheumatology/keaa401. IF:7,58.
